https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q3-2023/
0
0
AZN Stock Jumps On $2 Billion Bet In Weight-Loss Drugs - Investor's Business Daily
11/9/23 at 10:02pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
33 words
0
Comments
The company is licensing a new GLP-1 drug in the hopes of taking on Novo and Lilly.
You are the first to view
Create an account or login to join the discussion